|
|
Volumn 21, Issue 2, 2002, Pages 272-281
|
|
Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis
a a a |
|
Author keywords
Angiogenesis; Angiostatin; Doxycycline; MMP9
|
|
Indexed keywords
ALPHA1 INTEGRIN;
ANGIOSTATIN;
GELATINASE B;
INTEGRIN;
PLASMINOGEN;
UNCLASSIFIED DRUG;
ANGIOGENESIS;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CANCER GROWTH;
CANCER INHIBITION;
CANCER REGRESSION;
CARCINOGENESIS;
CELL GROWTH;
CELL PROLIFERATION;
CONTROLLED STUDY;
ENDOTHELIUM CELL;
ENZYME BLOOD LEVEL;
ENZYME INHIBITION;
ENZYME REGULATION;
ENZYME RELEASE;
ENZYME SYNTHESIS;
GENE OVEREXPRESSION;
MALE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN SYNTHESIS;
TUMOR VASCULARIZATION;
ANGIOSTATINS;
ANIMALS;
ANTIGENS, CD;
ANTINEOPLASTIC AGENTS;
CARCINOMA, RENAL CELL;
CELL DIVISION;
COLONIC NEOPLASMS;
DOXYCYCLINE;
ENDOTHELIUM, VASCULAR;
GROWTH SUBSTANCES;
INTEGRIN ALPHA1;
KIDNEY NEOPLASMS;
MATRIX METALLOPROTEINASE 9;
MICE;
MICE, INBRED BALB C;
MICE, INBRED STRAINS;
MICE, KNOCKOUT;
NEOVASCULARIZATION, PATHOLOGIC;
PEPTIDE FRAGMENTS;
PLASMINOGEN;
TUMOR CELLS, CULTURED;
ANIMALIA;
|
|
EID: 0037050259
PISSN: 09509232
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.onc.1205045 Document Type: Article |
|
Times cited : (141)
|
|
References (36)
|
